EUVIMEDEUVIMED entdecken
Crossref

Design and synthesis of uracil/thiouracil based quinoline scaffolds as topoisomerases I/II inhibitors for chemotherapy: A new hybrid navigator with DFT calculation

Samar El-Kalyoubi, Samar S Elbaramawi, Wael A Zordok, Azizah M Malebari, Martin K Safo, Tarek S Ibrahim, Ehab S Taher

Bioorganic Chemistry · 2023

DOI: 10.1016/j.bioorg.2023.106560 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic Chemistry, 2023. Verfasst von Samar El-Kalyoubi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Port Said University, 42511 Port Said, Egypt. Electronic address: s.elkalyoubi@h…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Quinolines. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Deanship of Scientific Research, King Saud University, King Abdulaziz University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this work, a novel promising hybrid mode of uracil/thiouracil based quinoline pharmacophore i.e. 5a-f was rationalized and synthesized based on rigidification and lipophilic principles, and following the reported pharmacophoric features of camptothecin & doxorubicin. Concurrently, a non-rigid mode pharmacophore i.e. 7a-f was also designed and synthesized. The anti-proliferative activity of the compounds was assessed against three different cancer cell lines, namely A549 lung cancer, MCF-7 breast adenocarcinoma, and HepG-2 hepatic carcinoma. Further, promising candidates were evaluated against A549, and MCF-7 and for their ability to inhibit topoisomerases I &II. Compound 5f was observed to be the most active congener, displaying the highest cell inhibition of 84.4% for topoisomerase I and 92%, for topoisomerase II at a concentration of 100 µM. When its cytotoxicity was evaluated against A549 cells, 5f arrested the cell cycle at the S phase and increased the apoptosis ratio by 46.31%. DFT calculation of 5f showed higher dipole moment and greater negative energy values (-247531.510 kcal/mol) with positive & negative poles, and better stability reflection. Furthermore, molecular docking of 5f to both enzymes showed good agreement with the biological assessment. This study has given insight for further consideration of the highly promising hybrid 5f.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsQuinolinesMolecular StructureStructure-Activity RelationshipThiouracilMolecular Docking SimulationUracilDensity Functional TheoryDrug Screening Assays, AntitumorTopoisomerase II InhibitorsCell ProliferationCell Line, TumorDNA Topoisomerases, Type II

Stichwörter der Autor:innen

AnticancerDFTHealthcareMolecular dockingQuinolineTopoisomerase I & IIUracil/thiouracil

Substanzen

Antineoplastic AgentsThiouracilUracilTopoisomerase II InhibitorsQuinolinesDNA Topoisomerases, Type II

Autor:innen und Institutionen

  • Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Port Said University, 42511 Port Said, Egypt. Electronic address: s.elkalyoubi@hotmail.com.
  • Department of Medicinal Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt. Electronic address: SSElbaramawy@pharmacy.zu.edu.eg.
  • Department of Chemistry (Physical Chemistry Division), Faculty of Science, Zagazig University, Zagazig 44519, Egypt. Electronic address: wazordok@zu.edu.eg.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia. Electronic address: amelibary@kau.edu.sa.
  • Institute for Structural Biology, Drug Discovery and Development, Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, VA, USA. Electronic address: msafo@vcu.edu.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, King Abdulaziz University, Jeddah 21589, Saudi Arabia. Electronic address: tmabrahem@kau.edu.sa.

Förderung

  • Deanship of Scientific Research, King Saud University
  • King Abdulaziz University

Zitieren

APA

El-Kalyoubi, S., Elbaramawi, S. S., Zordok, W. A., Malebari, A. M., Safo, M. K., Ibrahim, T. S., & Taher, E. S. (2023). Design and synthesis of uracil/thiouracil based quinoline scaffolds as topoisomerases I/II inhibitors for chemotherapy: A new hybrid navigator with DFT calculation. Bioorganic Chemistry. https://doi.org/10.1016/j.bioorg.2023.106560

Vancouver

El-Kalyoubi S, Elbaramawi SS, Zordok WA, Malebari AM, Safo MK, Ibrahim TS, et al. Design and synthesis of uracil/thiouracil based quinoline scaffolds as topoisomerases I/II inhibitors for chemotherapy: A new hybrid navigator with DFT calculation. Bioorganic Chemistry. 2023. doi:10.1016/j.bioorg.2023.106560

BibTeX
@article{ElKalyoubi2023,
  author = {El-Kalyoubi, Samar and Elbaramawi, Samar S and Zordok, Wael A and Malebari, Azizah M and Safo, Martin K and Ibrahim, Tarek S and Taher, Ehab S},
  title = {Design and synthesis of uracil/thiouracil based quinoline scaffolds as topoisomerases I/II inhibitors for chemotherapy: A new hybrid navigator with DFT calculation},
  journal = {Bioorganic Chemistry},
  year = {2023},
  doi = {10.1016/j.bioorg.2023.106560}
}
Kostenlos starten →